Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions

REFERENCES

• Meek DW, Hupp TR. 2010. The regulation of MDM2 by multisite phosphorylation–opportunities for molecular-based intervention to target tumours? Semin Cancer Biol 20:19–28. http://dx.doi.org/10.1016/j.semcancer.2009.10.005.
   PubMedGoogle Scholar
• Fahraeus R, Olivares-Illana V. 2014. MDM2's social network. Oncogene 33:4365–4376. http://dx.doi.org/10.1038/onc.2013.410.
   PubMedGoogle Scholar
• Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH, Yuan A, Lin CW, Yang SC, Chan WK, Li KC, Hong TM, Yang PC. 2009. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 11:694–704. http://dx.doi.org/10.1038/ncb1875.
   PubMed Web of Science ®Google Scholar
• Riemenschneider MJ, Buschges R, Wolter M, Reifenberger J, Bostrom J, Kraus JA, Schlegel U, Reifenberger G. 1999. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59:6091–6096.
   PubMed Web of Science ®Google Scholar
• Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80–83. http://dx.doi.org/10.1038/358080a0.
   PubMed Web of Science ®Google Scholar
• Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 29:92–95. http://dx.doi.org/10.1038/ng714.
   PubMedGoogle Scholar
• Montes de Oca Luna R, Amelse LL, Chavez-Reyes A, Evans SC, Brugarolas J, Jacks T, Lozano G. 1997. Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality. Nat Genet 16:336–337. http://dx.doi.org/10.1038/ng0897-336.
   PubMedGoogle Scholar
• Montes de Oca Luna R, Wagner DS, Lozano G. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203–206. http://dx.doi.org/10.1038/378203a0.
   PubMed Web of Science ®Google Scholar
• Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, Jochemsen AG, Parant J, Lozano G, Yuan ZM. 2002. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem 277:19251–19254. http://dx.doi.org/10.1074/jbc.C200150200.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang J, Jiang X. 2011. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J Biol Chem 286:23725–23734. http://dx.doi.org/10.1074/jbc.M110.213868.
   PubMedGoogle Scholar
• Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677.
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11:3471–3481.
   PubMed Web of Science ®Google Scholar
• Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334.
   PubMed Web of Science ®Google Scholar
• Gannon HS, Woda BA, Jones SN. 2012. ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell 21:668–679. http://dx.doi.org/10.1016/j.ccr.2012.04.011.
   PubMedGoogle Scholar
• Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V, Fahraeus R. 2012. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell 21:25–35. http://dx.doi.org/10.1016/j.ccr.2011.11.016.
   PubMed Web of Science ®Google Scholar
• Malbert-Colas L, Ponnuswamy A, Olivares-Illana V, Tournillon AS, Naski N, Fahraeus R. 2014. HDMX folds the nascent p53 mRNA following activation by the ATM kinase. Mol Cell 54:500–511. http://dx.doi.org/10.1016/j.molcel.2014.02.035.
   PubMedGoogle Scholar
• Toledo F, Krummel KA, Lee CJ, Liu CW, Rodewald LW, Tang M, Wahl GM. 2006. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 9:273–285. http://dx.doi.org/10.1016/j.ccr.2006.03.014.
   PubMed Web of Science ®Google Scholar
• Wade M, Wang YV, Wahl GM. 2010. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20:299–309. http://dx.doi.org/10.1016/j.tcb.2010.01.009.
   PubMedGoogle Scholar
• Peng Z, Mizianty MJ, Kurgan L. 2014. Genome-scale prediction of proteins with long intrinsically disordered regions. Proteins 82:145–158. http://dx.doi.org/10.1002/prot.24348.
   PubMedGoogle Scholar
• Peng Z, Xue B, Kurgan L, Uversky VN. 2013. Resilience of death: intrinsic disorder in proteins involved in the programmed cell death. Cell Death Differ 20:1257–1267. http://dx.doi.org/10.1038/cdd.2013.65.
   PubMedGoogle Scholar
• Terakawa T, Higo J, Takada S. 2014. Multi-scale ensemble modeling of modular proteins with intrinsically disordered linker regions: application to p53. Biophys J 107:721–729. http://dx.doi.org/10.1016/j.bpj.2014.06.026.
   PubMedGoogle Scholar
• Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, Obradovic Z, Dunker AK. 2004. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32:1037–1049. http://dx.doi.org/10.1093/nar/gkh253.
   PubMedGoogle Scholar
• Li X, Romero P, Rani M, Dunker AK, Obradovic Z. 1999. Predicting protein disorder for N-, C-, and internal regions. Genome Inform Ser Workshop Genome Inform 10:30–40.
   PubMedGoogle Scholar
• Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, Bourougaa K, Calvo F, Fahraeus R. 2008. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 10:1098–1105. http://dx.doi.org/10.1038/ncb1770.
   PubMedGoogle Scholar
• Reyes-Vivas H, Martinez-Martinez E, Mendoza-Hernandez G, Lopez-Velazquez G, Perez-Montfort R, Tuena de Gomez-Puyou M, Gomez-Puyou A. 2002. Susceptibility to proteolysis of triosephosphate isomerase from two pathogenic parasites: characterization of an enzyme with an intact and a nicked monomer. Proteins 48:580–590. http://dx.doi.org/10.1002/prot.10179.
   PubMedGoogle Scholar
• De La Mora-De La Mora I, Torres-Larios A, Mendoza-Hernandez G, Enriquez-Flores S, Castillo-Villanueva A, Mendez ST, Garcia-Torres I, Torres-Arroyo A, Gomez-Manzo S, Marcial-Quino J, Oria-Hernandez J, Lopez-Velazquez G, Reyes-Vivas H. 2013. The E104D mutation increases the susceptibility of human triosephosphate isomerase to proteolysis. Asymmetric cleavage of the two monomers of the homodimeric enzyme. Biochim Biophys Acta 1834:2702–2711. http://dx.doi.org/10.1016/j.bbapap.2013.08.012.
   PubMedGoogle Scholar
• Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M. 2008. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 32:180–189. http://dx.doi.org/10.1016/j.molcel.2008.08.031.
   PubMedGoogle Scholar
• Naski N, Gajjar M, Bourougaa K, Malbert-Colas L, Fahraeus R, Candeias MM. 2009. The p53 mRNA-Mdm2 interaction. Cell Cycle 8:31–34.
   PubMed Web of Science ®Google Scholar
• Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, Byeon IJ, Gabizon R, Mattia M, Zupnick A, Brown LM, Friedler A, Prives C. 2010. The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol 17:982–989. http://dx.doi.org/10.1038/nsmb.1872.
   PubMedGoogle Scholar
• Chen J, Marechal V, Levine AJ. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 13:4107–4114.
   PubMed Web of Science ®Google Scholar
• Elenbaas B, Dobbelstein M, Roth J, Shenk T, Levine AJ. 1996. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol Med 2:439–451.
   PubMed Web of Science ®Google Scholar
• Linke K, Mace PD, Smith CA, Vaux DL, Silke J, Day CL. 2008. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ 15:841–848. http://dx.doi.org/10.1038/sj.cdd.4402309.
   PubMedGoogle Scholar
• Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A, Teunisse A, Migliorini D, Kitabayashi I, Marine JC, Prives C, Shiloh Y, Jochemsen AG, Taya Y. 2005. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol 25:9608–9620. http://dx.doi.org/10.1128/MCB.25.21.9608-9620.2005.
   PubMedGoogle Scholar
• Kawai H, Wiederschain D, Kitao H, Stuart J, Tsai KK, Yuan ZM. 2003. DNA damage-induced MDMX degradation is mediated by MDM2. J Biol Chem 278:45946–45953. http://dx.doi.org/10.1074/jbc.M308295200.
   PubMed Web of Science ®Google Scholar
• Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M. 1999. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 447:5–9.
   PubMed Web of Science ®Google Scholar
• Waning DL, Lehman JA, Batuello CN, Mayo LD. 2011. c-Abl phosphorylation of Mdm2 facilitates Mdm2-Mdmx complex formation. J Biol Chem 286:216–222. http://dx.doi.org/10.1074/jbc.M110.183012.
   PubMedGoogle Scholar
• Wang X. 2011. p53 regulation: teamwork between RING domains of Mdm2 and MdmX. Cell Cycle 10:4225–4229. http://dx.doi.org/10.4161/cc.10.24.18662.
   PubMedGoogle Scholar
• Kostic M, Matt T, Martinez-Yamout MA, Dyson HJ, Wright PE. 2006. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J Mol Biol 363:433–450. http://dx.doi.org/10.1016/j.jmb.2006.08.027.
   PubMedGoogle Scholar
• Kawai H, Wiederschain D, Yuan ZM. 2003. Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol Cell Biol 23:4939–4947.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Song T, Chen L, Chen J. 2014. Autoactivation of the MDM2 E3 ligase by intramolecular interaction. Mol Cell Biol 34:2800–2810. http://dx.doi.org/10.1128/MCB.00246-14.
   PubMedGoogle Scholar
• Robert X, Gouet P. 2014. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42:W320–W324. http://dx.doi.org/10.1093/nar/gku316.
   Google Scholar
• Ye YH, Rape M. 2009. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 10:755–764. http://dx.doi.org/10.1038/nrm2780.
   PubMed Web of Science ®Google Scholar
• Li W, Ye Y. 2008. Polyubiquitin chains: functions, structures, and mechanisms. Cell Mol Life Sci 65:2397–2406. http://dx.doi.org/10.1007/s00018-008-8090-6.
   PubMed Web of Science ®Google Scholar
• Ambivero CT, Cilenti L, Main S, Zervos AS. 2014. Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP. Cell Signal 26:2921–2929. http://dx.doi.org/10.1016/j.cellsig.2014.09.004.
   PubMed Web of Science ®Google Scholar
• Bista M, Petrovich M, Fersht AR. 2013. MDMX contains an autoinhibitory sequence element. Proc Natl Acad Sci U S A 110:17814–17819. http://dx.doi.org/10.1073/pnas.1317398110.
   PubMedGoogle Scholar
• Chen L, Borcherds W, Wu S, Becker A, Schonbrunn E, Daughdrill GW, Chen J. 2015. Autoinhibition of MDMX by intramolecular p53 mimicry. Proc Natl Acad Sci U S A 112:4624–4629. http://dx.doi.org/10.1073/pnas.1420833112.
   PubMed Web of Science ®Google Scholar